TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - IDEXX LABORATORIES Share Price

Certificat

DE000SV2H096

Delayed Deutsche Boerse AG 08:55:25 20/06/2024 BST
1.41 EUR -1.40% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - IDEXX LABORATORIES
Current month-5.92%
1 month+33.64%
Date Price Change
20/06/24 1.41 -1.40%
19/06/24 1.43 -1.38%
18/06/24 1.45 0.00%
17/06/24 1.45 0.00%
14/06/24 1.45 +1.40%

Delayed Quote Deutsche Boerse AG

Last update June 20, 2024 at 08:55 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying IDEXX LABORATORIES, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SV2H09
ISINDE000SV2H096
Date issued 23/03/2023
Strike 657.8 $
Maturity Unlimited
Parity 100 : 1
Emission price 1.48
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.66
Lowest since issue 0.7
Spread 0.07
Spread %4.76%

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
503.6 USD
Average target price
565.1 USD
Spread / Average Target
+12.20%
Consensus